Enhanced Recovery After Surgery (ERAS) With Exparel in Tissue Expander–based Breast Reconstruction Following Mastectomy
Aesthetic Surgery Journal · 2024
DOI: 10.1093/asj/sjae003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aesthetic Surgery Journal, 2024. Verfasst von Nicholas T Haddock und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Mastectomy, Bupivacaine, Mammaplasty, Enhanced Recovery After Surgery. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Pacira BioSciences, Inc.
Abstract (Originalsprache)
Background
Enhanced recovery after surgery (ERAS) pathways have been widely shown to yield positive outcomes, including in plastic surgery. Our group has previously validated ERAS in our deep inferior epigastric perforator flap breast reconstruction population.
Objectives
We evaluated whether the ERAS protocol and addition of liposomal bupivacaine affected patient outcomes at the time of mastectomy and first-stage tissue expander reconstruction.
Methods
All patients treated between July 2021 and May 2022 were reviewed retrospectively. The ERAS protocol was implemented in December 2021. Two patient groups were compared: pre-ERAS and ERAS. The ERAS protocol included use of liposomal bupivacaine in the pectoralis nerve block 1/2 planes. Primary outcomes were observed with postoperative length of stay and hospital narcotic use.
Results
Eighty-one patients were analyzed in this cohort. The pre-ERAS group was composed of 41 patients, the ERAS group was composed of 83 patients. Postoperative length of stay was significantly reduced in the ERAS group (1.7 pre-ERAS vs 1.1 ERAS, P = .0004). When looking at morphine equivalents during the hospital stay, the degree of narcotics in the recovery room was relatively similar. Average PACU pain morphine equivalents were 6.1 pre-ERAS vs 7.1 ERAS (P = .406). However, total hospital morphine equivalents were significantly lower in the ERAS group (65.0 pre-ERAS vs 26.2 ERAS, P = <.001).
Conclusions
The introduction of an enhanced recovery after surgery protocol with liposomal bupivacaine pectoralis 1/2 nerve blocks decreased postoperative opioid consumption and hospital length of stay in mastectomy patients undergoing tissue expander–based reconstruction. Level of Evidence: 4
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Pacira BioSciences, Inc
Zitieren
APA
Haddock, N. T., Cummins, S., Lakatta, A. C., Teotia, S. S., & Farr, D. (2024). Enhanced Recovery After Surgery (ERAS) With Exparel in Tissue Expander–based Breast Reconstruction Following Mastectomy. Aesthetic Surgery Journal. https://doi.org/10.1093/asj/sjae003
Vancouver
Haddock NT, Cummins S, Lakatta AC, Teotia SS, Farr D. Enhanced Recovery After Surgery (ERAS) With Exparel in Tissue Expander–based Breast Reconstruction Following Mastectomy. Aesthetic Surgery Journal. 2024. doi:10.1093/asj/sjae003
BibTeX
@article{Haddock2024,
author = {Haddock, Nicholas T and Cummins, Samantha and Lakatta, Alexis C and Teotia, Sumeet S and Farr, Deborah},
title = {Enhanced Recovery After Surgery (ERAS) With Exparel in Tissue Expander–based Breast Reconstruction Following Mastectomy},
journal = {Aesthetic Surgery Journal},
year = {2024},
doi = {10.1093/asj/sjae003}
}
EUVIMED